Augtyro (repotrectinib) is an oral prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread within your chest or to other parts of the body and is caused by an abnormal ROS1 gene.
It is not known if AUGTYRO is safe and effective in children with ROS1-positive NSCLC.
AUGTYRO (repotrectinib) is an oral prescription medicine used to treat adults and children 12 years and older with solid tumors (cancer) that are caused by certain abnormal NTRK genes, and have spread to other parts of the body or if surgery to remove your cancer is likely to cause severe complications, and have grown or spread after any other treatment or there is no satisfactory alternative treatment option.
It is not known if AUGTYRO is safe and effective in children younger than 12 years of age with NTRK-positive solid tumors.